The Sentri7 Pharmacy Module integrated with Lexicomp drug information and clinical content, is expected to improve patient outcomes at the point-of-care and also allows pharmacists, physicians and nurses
ChondroCelect is the company’s commercial cell therapy product for cartilage repair in the knee. TiGenix CEO Eduardo Bravo said the EMA has approved the Netherlands facility for the
Amitiza, a chloride channel activator, is indicated for the treatment of chronic idiopathic constipation (CIC) in adults and for irritable bowel syndrome with constipation in 18 year and
Cobas 4800 system, a new analyzer, performs DNA-based tests and will be tested with cobas HPV (Human Papillomavirus) test, a new cervical cancer screening test approved by the
With the severe shortage of usable water, Goa-based pharma industries are depending on tanker water to manufacture drug products. Goa Pharmaceutical Manufacturers Association president A K Burman was
Fycompa, which was discovered and developed in the UK and Japan, was first launched globally in the UK on 12 September 2012. The production of the drug will
The company expects the process of activation, recruitment, enrolling and first dosing to take nearly 3 weeks. Cellceutix president and chief scientific officer Krishna Menon said institutions such
The two-year, $582,763 grant will be used to develop Biodel’s proprietary glucagon to deliver it as part of a bihormonal closed loop system to mitigate hypoglycemic events. Biodel
Tacrolimus, developed by Astellas, is a once daily formulation of calcineurin-inhibitor immunosuppressant tacrolimus. Astellas global transplantation therapeutic area head Roy First said there remains a large unmet treatment
Equipped with Bruker’s self-optimizing ScanAsyst Imaging Mode and PeakForce TUNA module, the AFM system is designed for use in conductivity mapping as well as to characterize other difficult
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.